A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
Clinical trial NCT04964479 · UNKNOWN
Trial details
- NCT number
- NCT04964479
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2022-12-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.